133 related articles for article (PubMed ID: 8377304)
21. [Evaluation of CA 19-9 radioimmunoassay].
Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
[TBL] [Abstract][Full Text] [Related]
22. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
[TBL] [Abstract][Full Text] [Related]
23. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
24. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
Yu Q; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
[TBL] [Abstract][Full Text] [Related]
25. [Basic and clinical evaluation of a novel immunoradiometric assay kit for free thyroxine].
Misaki T; Kousaka T; Miyamoto S; Takeuchi R; Kasagi K; Konishi J
Kaku Igaku; 1994 Jun; 31(6):629-35. PubMed ID: 8072238
[TBL] [Abstract][Full Text] [Related]
26. [Basic and clinical studies on ELSA CA 125 RIA kit: usefulness in patients with ovarian carcinoma].
Sakahara H; Endo K; Nakajima K; Nakashima T; Koizumi M; Ohta H; Torizuka K; Konishi I; Fujii S; Mori T
Kaku Igaku; 1985 Sep; 22(9):1391-7. PubMed ID: 3866873
[No Abstract] [Full Text] [Related]
27. [Evaluation of CA 15-3 radioimmunoassay].
Takemori Y; Odani H; Watanabe H; Ohta H; Satomura Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654
[TBL] [Abstract][Full Text] [Related]
28. [Basic and clinical studies on SPan-1 RIABEAD kit: usefulness in patients with pancreatic and biliary tract cancer].
Watanabe Y; Endo K; Nakajima K; Hattori N; Sakahara H; Saga T; Nakai T; Hosono M; Yao ZS; Baba N
Kaku Igaku; 1989 Dec; 26(12):1559-65. PubMed ID: 2622087
[No Abstract] [Full Text] [Related]
29. [Basic and clinical evaluation of CA 130 RIA kit (D-7111) using two newly developed monoclonal antibodies; comparison with CA 125 kit].
Saga T; Endo K; Nakashima T; Nakajima K; Matsuoka Y; Koizumi M; Kawamura Y; Watanabe Y; Hato A; Kunimatsu M
Kaku Igaku; 1988 Oct; 25(10):1163-70. PubMed ID: 3221514
[No Abstract] [Full Text] [Related]
30. [Fundamental and clinical evaluation of an immunoradiometric assay procedure "Amerwell AFP" for estimation of serum alpha-fetoprotein].
Suzuki M
Radioisotopes; 1988 Apr; 37(4):225-8. PubMed ID: 2456592
[TBL] [Abstract][Full Text] [Related]
31. [Basic and clinical studies on "ELSA CA 15-3" kit].
Sakahara H; Endo K; Nakajima K; Koizumi M; Nakashima T; Kawamura Y; Ohta H; Inamoto T; Ozawa K; Torizuka K
Kaku Igaku; 1986 Oct; 23(10):1485-90. PubMed ID: 3469451
[No Abstract] [Full Text] [Related]
32. Characterization of CA125 glycoprotein using 3 monoclonal antibodies with different specificities.
Kobayashi F; Sagawa N; Fujii S; Mori T; Endo K
Gynecol Obstet Invest; 1994; 37(3):199-203. PubMed ID: 8005553
[TBL] [Abstract][Full Text] [Related]
33. Discordant serum CA 125 values in commercial immunoassays.
van Kamp GJ; Verstraeten AA; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of serum SC6 antigen using immunoradiometric assay for diagnosis of pancreatic cancer].
Guo XZ; Liu MP; Li XX
Zhonghua Nei Ke Za Zhi; 1992 Feb; 31(2):84-6, 125. PubMed ID: 1395920
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the temporal compressibility of breast tumour marker assays: development of a "near patient" assay.
Murray A; Robertson JF; Price MR
Int J Biol Markers; 1995; 10(4):200-5. PubMed ID: 8750645
[TBL] [Abstract][Full Text] [Related]
36. Tumor antigen markers for the detection of solid cancers in inflammatory myopathies.
Amoura Z; Duhaut P; Huong DL; Wechsler B; Costedoat-Chalumeau N; Francès C; Cacoub P; Papo T; Cormont S; Touitou Y; Grenier P; Valeyre D; Piette JC
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1279-82. PubMed ID: 15894686
[TBL] [Abstract][Full Text] [Related]
37. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
38. Basic evaluation of an immunoradiometric competitive inhibition assay for sialosyl-Tn antigen in sera in women. Assay conditions and normal values.
Ryuko K; Iwanari O; Nakayama S; Kitao M; Karino K; Endo J
Cancer; 1992 May; 69(9):2361-7. PubMed ID: 1562984
[TBL] [Abstract][Full Text] [Related]
39. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].
Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3213-9. PubMed ID: 2782915
[TBL] [Abstract][Full Text] [Related]
40. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies.
Saga T; Ishiwata I; Endo K; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Ishikawa H; Sawada M
Jpn J Cancer Res; 1990 Nov; 81(11):1141-8. PubMed ID: 2125039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
